Key Takeaways Umbilical cord MSCs for stroke are being studied as a possible add-on to standard rehabilitation, not a replacement for it. A 2025 randomized trial in 32 patients found IV delivery led to significant improvements at 6 months, with both IV and intrathecal groups improving by 12 months. A
Key Takeaways Stem cell therapy after spinal cord injury is studied for both traumatic and chronic cases, with different goals at each stage. A 2024 study found durable motor and sensory improvements in some patients five years after neural stem cell transplantation. A 2026 trial reported no serious safety concerns
Key Takeaways Traumatic brain injury (TBI) often causes lasting neurological deficits, since the brain has limited ability to repair itself after trauma. Stem cell therapy is being studied as a supportive treatment option that may calm inflammation and support the brain’s own repair signals. A Phase 2 controlled trial found
Key Takeaways Hypoxic brain injury is caused by reduced oxygen; anoxic brain injury by a complete stop. Both damage the same brain tissue but anoxic injuries tend to be more severe. Stem cell therapy supports recovery in both by releasing neurotrophic factors, reducing inflammation, and providing an environment for surviving
Key Takeaways The realistic goals of stem cell therapy for MS are slowing disease activity, reducing fatigue, and improving mobility, not reversing all past damage. Mesenchymal stem cells (MSCs) calm the immune system and protect nerve fibers. Hematopoietic stem cell transplant (HSCT) goes further, aiming to reset the immune system
Quick Summary TreeFrog Therapeutics announced preclinical data for TFG‑001, a 3D neural microtissue therapy for Parkinson’s disease. The approach aims to replace damaged dopamine‑producing neurons. Preclinical models showed rapid dopamine release, nerve regrowth, and motor recovery. However, the work is still preclinical; a Clinical Trial Application is expected in 2027.
Quick Summary Stem cell therapy for Alzheimer’s uses mesenchymal stem cells (MSCs), neural stem cells (NSCs), or induced pluripotent stem cells (iPSCs) to repair damaged brain cells, reduce inflammation, and support the central nervous system. Early-stage patients may see improved memory and slower decline, but treatment is not yet a
Quick Summary Mesenchymal stem cells (MSCs) help regulate immune responses in relapsing-remitting MS by interacting with immune cells, reducing inflammation, and providing neuroprotective effects. Unlike traditional immunosuppressive treatments, MSCs promote balanced immune modulation and may offer long-term stability with a favorable safety profile. How MSCs work: Interact with T cells
Quick Read Summary What Is Anoxic Brain Injury and How Can Stem Cell Therapy Support Recovery? Anoxic brain injury happens when the brain does not receive enough oxygen. As a result, brain cells and blood vessels become damaged. Stem cell therapy, part of regenerative medicine, may support brain repair, improve
Quick Read Summary When a loved one faces Alzheimer’s, families need realistic expectations for stem cell therapy in Alzheimer’s disease what families need to know. Stem cell treatment uses mesenchymal stem cells mscs and other adult stem cells to release growth factors that may support brain health. However, stem cell
